Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of small molecule inhibitors to KLF10 for modulation of T regulatory cells and cancer immunotherapy

Use of small molecule inhibitors to KLF10 for modulation of T regulatory cells and cancer immunotherapy

US Patent 11267807 · Granted Mar 8, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Tubulin binding compounds and therapeutic use thereof2025
Use of small molecule inhibitors to KLF10 for modulation of T regulatory cells a2025
Use of small molecule inhibitors to KLF10 for modulation of T regulatory cells a2025
Replication-competent attenuated chimeric VSV vectors encoding immunogenic SARS-2025
Tubulin binding compounds and therapeutic use thereof2023
UBE2K modulators and methods for their use2021
Enhancing dermal wound healing by downregulating microRNA-26a2019
Detection of organ rejection2017
Methods of treating vascular inflammatory disorders2017
Vitamin D receptor agonists and uses thereof2016
Kruppel-like factor 10 (KLF10) as a biomarker of endothelial progenitor cell dys2016
Methods of using microRNA-26a to promote angiogenesis2016